Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine test as a biomarker of relapse in substance-dependent patients
2004-001929-20Phase 2Active
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of apomorphine in substance use disorder (SUD), alcohol dependence, cocaine use disorder (CUD) and 1 more (2 arms), sponsored by Vall d'Hebron University Hospital. Primary endpoints: Sensitivity of the apomorphine test as a predictor of relapse and Correlation between yawning response and relapse over 12 weeks. Started Nov 2009; status: active.
02
Drugs
apomorphine
03
Conditions
substance use disorder (SUD)alcohol dependencecocaine use disorder (CUD)opioid use disorder (OUD)
Beyond the preview
Go deeper on 2004-001929-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001929-20.